We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RKT
1551
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $147K | ﹤0.01% |
+2,289
| New | +$150K |
|
|
GSIG
1552
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $146K | ﹤0.01% |
11,002
-18,498
| -63% | -$248K |
|
|
MCF
1553
DELISTED
Contango Oil & Gas Co.
MCF
| $143K | ﹤0.01% |
6,500
-200
| -3% | -$5.14K |
|
1554
Nektar Therapeutics
NKTR
$2.39B
| $141K | ﹤0.01% |
858
-260
| -23% | -$53.4K |
|
|
OCR
1555
DELISTED
OMNICARE INC
OCR
| $141K | ﹤0.01% |
+1,830
| New | +$139K |
|
1556
Horizon Bancorp
HBNC
$1.03B
| $140K | ﹤0.01% |
13,500
-450
| -3% | -$4.68K |
|
|
BEAT
1557
DELISTED
BioTelemetry, Inc.
BEAT
| $140K | ﹤0.01% |
+15,900
| New | +$161K |
|
1558
Celanese
CE
$5.09B
| $138K | ﹤0.01% |
+2,476
| New | +$140K |
|
|
TW
1559
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $137K | ﹤0.01% |
+1,037
| New | +$130K |
|
1560
Steven Madden
SHOO
$3.12B
| $136K | ﹤0.01% |
5,400
+3,000
| +125% | +$70.2K |
|
1561
Western Alliance Bancorporation
WAL
$9.07B
| $136K | ﹤0.01% |
4,600
+500
| +12% | +$13.9K |
|
|
GWB
1562
DELISTED
Great Western Bancorp, Inc.
GWB
| $136K | ﹤0.01% |
6,200
-200
| -3% | -$4.39K |
|
1563
AXIS Capital
AXS
$8.59B
| $135K | ﹤0.01% |
+2,635
| New | +$134K |
|
1564
Independent Bank Corp
IBCP
$776M
| $135K | ﹤0.01% |
10,600
+5,000
| +89% | +$63.5K |
|
|
CADE
1565
DELISTED
Cadence Bank
CADE
| $134K | ﹤0.01% |
5,800
-2,600
| -31% | -$56.7K |
|
1566
MIND Technology
MIND
$50.4M
| $133K | ﹤0.01% |
2,900
-70
| -2% | -$4.14K |
|
1567
H.B. Fuller
FUL
$3B
| $132K | ﹤0.01% |
3,100
-100
| -3% | -$4.28K |
|
1568
Nucor
NUE
$56.4B
| $132K | ﹤0.01% |
2,788
-6,469
| -70% | -$302K |
|
|
MWV
1569
DELISTED
MEADWESTVACO CORP
MWV
| $132K | ﹤0.01% |
+2,663
| New | +$133K |
|
1570
International Flavors & Fragrances
IFF
$19.4B
| $131K | ﹤0.01% |
+1,116
| New | +$126K |
|
1571
Principal Financial Group
PFG
$23.6B
| $131K | ﹤0.01% |
2,557
-3,402
| -57% | -$171K |
|
1572
Texas Capital Bancshares
TCBI
$4.31B
| $131K | ﹤0.01% |
2,700
-2,100
| -44% | -$99K |
|
|
LMOS
1573
DELISTED
Lumos Networks Corp
LMOS
| $131K | ﹤0.01% |
+8,623
| New | +$145K |
|
|
CCRN
1574
DELISTED
Cross Country Healthcare
CCRN
| $130K | ﹤0.01% |
11,000
-300
| -3% | -$3.44K |
|
1575
CarMax
KMX
$8.27B
| $130K | ﹤0.01% |
+1,884
| New | +$123K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.